Markets:

Overview

News

Currencies

International

Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

26.05 +7.53 (+40.63%)

Streaming Delayed Price Updated: 1:48 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Top movers in Friday's session ↗

Today 12:30 EST

Via Chartmill

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

Today 10:30 EST

Via Chartmill

Why Did TNDM Stock Jump 5% After Hours Despite Q4 Earnings Miss? ↗

Today 1:46 EST

For the full year, Tandem reported $1.015 billion in worldwide sales and over 126,000 pump shipments.

Via Stocktwits

Topics Earnings

Tandem Diabetes Care Inc (NASDAQ:TNDM) Reports Strong Q4 Beat but Issues Cautious 2026 Sales Guidance ↗

February 19, 2026

Via Chartmill

Tandem Diabetes’s (NASDAQ:TNDM) Q4 CY2025 Sales Top Estimates

February 19, 2026

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 15% year on year to $290.4 million. On the other hand, the company’s...

Via StockStory

Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results and 2026 Financial Guidance

February 19, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Insulet (PODD) Shakes the Market with Q4 Earnings Beat as Omnipod 5 Dominance Continues

February 18, 2026

Insulet Corporation (NASDAQ:PODD) delivered a commanding performance in its fourth-quarter earnings report released today, February 18, 2026. The medical device leader announced an adjusted earnings...

Via MarketMinute

Topics Earnings

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Question

February 15, 2026

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Tandem Diabetes Care Announces Upcoming Conference Presentations

February 12, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

February 08, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

1 Small-Cap Stock with Exciting Potential and 2 Facing Headwinds

February 02, 2026

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

February 02, 2026

From The Rosen Law Firm PA

Via GlobeNewswire

3 Stocks Under $50 That Fall Short

January 29, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

Chart Industries Exit Comes With a $210 Takeout Clock and $6 Billion Backlog ↗

January 29, 2026

Chart Industries supplies cryogenic and heat transfer equipment to energy, industrial gas, and specialty markets worldwide.

Via The Motley Fool

Topics Regulatory Compliance Supply Chain

Knife River Stock Has Tumbled 31% This Past Year, but One Fund Placed a $22 Million Bet on a Turnaround ↗

January 29, 2026

Knife River delivers construction materials and services for large U.S. infrastructure projects, serving both public and private clients.

Via The Motley Fool

3 Reasons to Avoid TNDM and 1 Stock to Buy Instead

January 25, 2026

Over the past six months, Tandem Diabetes has been a great trade, beating the S&P 500 by 9.6%. Its stock price has climbed to $19.83, representing a healthy 17.8% increase. This was partly due to its...

Via StockStory

Topics Bankruptcy Stocks

Precision Medicine and the Tubeless Revolution: An In-Depth Look at Insulet Corporation (PODD)

January 09, 2026

Today’s Date: January 9, 2026 Introduction In the rapidly evolving landscape of medical technology, few companies have managed to fundamentally reshape a multi-decade standard of care as successfully...

Via PredictStreet

Topics Economy Product Recall World Trade

Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026

January 08, 2026

From Tandem Diabetes Care, Inc.

Via Business Wire

Unpacking Q3 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks

December 18, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare technology stocks fared in Q3, starting with...

Via StockStory

Tandem t:slim Mobile App Now Available in Canada

December 18, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Don't Buy Tandem Diabetes Care Until This Big Thing Happens ↗

December 12, 2025

The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.

Via The Motley Fool

Topics Government World Trade

1 Small-Cap Stock to Consider Right Now and 2 We Brush Off

December 07, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Topics Firearms

Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know

December 03, 2025

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 4.5% in the afternoon session after an analyst at Morgan Stanley raised the firm's price target for the stock. The firm's...

Via StockStory

Topics Artificial Intelligence Economy Supply Chain

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

November 30, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

November 27, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

November 24, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Economy

2 Momentum Stocks with Solid Fundamentals and 1 We Turn Down

November 21, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

Topics Economy

5 Insightful Analyst Questions From Tandem Diabetes’s Q3 Earnings Call

November 13, 2025

Tandem Diabetes’ third quarter was marked by improved operational efficiency and commercial execution, resulting in a positive market reaction. Management credited the quarter’s performance to the...

Via StockStory

Topics Earnings

Tandem Diabetes Care Announces Appointment of Sandra Beaver to Board of Directors

November 12, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.